Global Blood Plasma Market -- A New Report by Koncept Analytics

March 25, 2010 - PRLog -- The global blood plasma products market has undergone drastic changes from the early days when plasma products were considered unsafe and a threat which can result in spreading of diseases like HIV to a product which now helps in saving lives & treating bleeding disorders and helps people to lead a normal life.

The global plasma products market has more than doubled over the period 2000-08 as a result of increase in demand and prices of plasma products. The worldwide plasma supply has increased but not at the same pace as the demand for the plasma products. The global plasma products market has been segmented on the basis of plasma proteins like immunoglobulin, albumin, clotting factors and other proteins. The IVIG or Immunoglobulin market is the largest segment of the plasma products market having more than fifty percent share of the market. The IVIG and Albumin segment has been real drivers of the global plasma products market as they witnessed double-digit growth rate over the last few years.

The US is the largest market for plasma products consumption as well as in terms of supply of human plasma, as more than fifty percent of global plasma supply comes from the US. The US regulation which allows companies to pay the donor of plasma has significantly contributed towards the high supply of plasma from the US.

Among the emerging markets, China is the most potential target market for plasma products. The market has grown significantly over the last few years. The changes in the Chinese plasma product market have significantly contributed towards the global mismatch of demand and supply of plasma and plasma products.

The report broadly includes the following

1. Plasma Market

2. Global Blood Plasma Market

2.1 Market Size
2.2 Market Segmentation
2.3 Supply Scenario of Plasma Market
2.4 Industry Cost Structure

3. China Plasma Market

4. Market Movements

4.1 Growth Drivers
4.2 Challenges

5. Competitive Scenario

6. Company Profiles

6.1 Baxter
6.2 CSL Ltd
6.3 Talecris
6.4 Octapharma

7. Market Outlook

List of Tables

Average Industrial Yields for Main Plasma Proteins
Comparison of Blood Products Utilization
Yearly Consumption of the Plasma Products per Million People
Investment strategy of Eight Major Fractionators
Dependent & Independent Variables, 2003– 2008
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Charts

Blood Constituents
Plasma Constituents
Proteins Present in Human Plasma
Value-Chain of Plasma Derived Products Market
Global Plasma-Derived Products Market, 2000-08
Global Plasma Market by Type of Proteins, 2008
Global Plasma-Derived IVIG Factors Market, 2000-2008
Geographical Break-up of Global IVIG market, 2008
Global Plasma-Derived Human Albumin Factors Market, 2000-2008
Evolution of Global Albumin Prices ($ per g), 1998-2007
Geographical Break-up of Global Albumin Market, 2008
Global Plasma-Derived Clotting Factors Market, 2000-2008
Breakdown of Global Plasma-Derived Clotting Factors Market, 2008
Global Prices of Plasma Derived Factor VIII prices, 1998-2007
Global Plasma-Derived Other Proteins Market, 2000-2008
Worldwide Origin of Plasma, 2002-2008
Plasma Collection by Geographical Area, 2006
Production Capacity of Main Fractionators (million of litres), 2008
Cost structure in Plasma Fractionation Business, 2008
Cost Structure in Pharma Business, 2008
China Plasma Product Market, 2001-2008
Regulations that Limit Raw Material Supply
Plasma Collection Volumes in China, 2003-2009E
New Drug Application (NDA) process: China SFDA Vs US FDA
Breakdown of Chinese Plasma Product Market
Number of Identified Patients (all Bleeding disorders), 1999-2008
Proportion of Old Age and Children Population, 1950-2010E
World Population, 2000-2008
Per Capita World GDP, 2003-2008
U.S. National Health Expenditure, 2000-2008
Global Plasma Fractionation Market, 2008
Plasma Collectors, 2000
Plasma Collectors, 2008
Baxter Company Revenues, 2005-2009
CSL Ltd Revenues, 2005-2009
Talecris Revenues, 2005-2009
Octapharma Revenues, 2004-2008
Global Plasma-derived Products Market Forecast, 2008-2012F

For more details, please visit http://www.konceptanalytics.com/reportDetail.aspx?reportI...

To know more about us visit http://www.konceptanalytics.com/

# # #

Koncept Analytics, founded in 2005, works with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.